• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Estimated Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017-March 2020.美国成年人丙型肝炎病毒感染的估计患病率和知晓率：2017 年 1 月至 2020 年 3 月全国健康和营养调查。
Clin Infect Dis. 2023 Nov 17;77(10):1413-1415. doi: 10.1093/cid/ciad411.
2
Estimating hepatitis C prevalence in the United States, 2017-2020.2017 - 2020年美国丙型肝炎患病率估算
Hepatology. 2025 Feb 1;81(2):625-636. doi: 10.1097/HEP.0000000000000927. Epub 2024 May 13.
3
Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.2010年美国各州及哥伦比亚特区丙型肝炎病毒感染的州级患病率估计
Clin Infect Dis. 2017 Jun 1;64(11):1573-1581. doi: 10.1093/cid/cix202.
4
Prevalence of Viremic Hepatitis C Virus Infection by Age, Race/Ethnicity, and Birthplace and Disease Awareness Among Viremic Persons in the United States, 1999-2016.1999-2016 年美国不同年龄、种族/族裔、出生地的血源传播丙型肝炎病毒感染者流行率以及血源传播丙型肝炎病毒感染者的疾病知晓率。
J Infect Dis. 2020 Jan 14;221(3):408-418. doi: 10.1093/infdis/jiz479.
5
Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016.2013 年至 2016 年美国各州和哥伦比亚特区丙型肝炎病毒感染流行率。
JAMA Netw Open. 2018 Dec 7;1(8):e186371. doi: 10.1001/jamanetworkopen.2018.6371.
6
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.美国慢性丙型肝炎病毒感染，2003 年至 2010 年全国健康和营养调查。
Ann Intern Med. 2014 Mar 4;160(5):293-300. doi: 10.7326/M13-1133.
7
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.估计 2013-2016 年美国丙型肝炎病毒感染的流行率。
Hepatology. 2019 Mar;69(3):1020-1031. doi: 10.1002/hep.30297. Epub 2018 Nov 6.
8
The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010.美国丙型肝炎病毒感染的流行趋势变化：2001 年至 2010 年全国健康和营养调查。
J Hepatol. 2014 Apr;60(4):691-8. doi: 10.1016/j.jhep.2013.11.014. Epub 2013 Nov 27.
9
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.1999年至2002年美国丙型肝炎病毒感染的流行情况。
Ann Intern Med. 2006 May 16;144(10):705-14. doi: 10.7326/0003-4819-144-10-200605160-00004.
10
Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study.一项基于人群的研究：美国病毒性肝炎认知方面的差距
Clin Gastroenterol Hepatol. 2020 Jan;18(1):188-195.e4. doi: 10.1016/j.cgh.2019.05.047. Epub 2019 Jun 4.

引用本文的文献

1
The Potential Impact of the Kennedy v. Braidwood Supreme Court Decision on Hepatitis C Diagnosis and Treatment in the United States.肯尼迪诉布雷德伍德最高法院判决对美国丙型肝炎诊断与治疗的潜在影响
Gastro Hep Adv. 2025 Jun 14;4(9):100722. doi: 10.1016/j.gastha.2025.100722. eCollection 2025.
2
Prevalence and awareness of hepatitis B and hepatitis C and vaccine-induced immunity to hepatitis B: Findings from the Canadian Health Measure Survey, 2016-2019.乙型肝炎和丙型肝炎的患病率、知晓率以及乙肝疫苗诱导的免疫力：2016 - 2019年加拿大健康测量调查结果
Can Commun Dis Rep. 2025 Jul 1;51(6-7):238-248. doi: 10.14745/ccdr.v51i67a03. eCollection 2025 Jul.
3
Hepatitis C Surveillance in the United States: Past, Present, and Future.美国丙型肝炎监测：过去、现在与未来
Public Health Rep. 2025 Aug 28:333549251351880. doi: 10.1177/00333549251351880.
4
Development and Validation of a Machine Learning-Based Screening Algorithm to Predict High-Risk Hepatitis C Infection.一种基于机器学习的用于预测丙型肝炎高风险感染的筛查算法的开发与验证
Open Forum Infect Dis. 2025 Aug 15;12(8):ofaf496. doi: 10.1093/ofid/ofaf496. eCollection 2025 Aug.
5
Racial Disparities in Comorbidity Patterns of Early-Onset Liver Cancer: A Machine Learning Analysis.早发性肝癌合并症模式中的种族差异：一项机器学习分析
Cancer Control. 2025 Jan-Dec;32:10732748251363687. doi: 10.1177/10732748251363687. Epub 2025 Jul 30.
6
Hepatitis C-Everything a Primary Care Physician Needs to Know About Diagnosis, Management, and Follow-Up.丙型肝炎——基层医疗医生需要了解的关于诊断、管理及随访的一切。
J Clin Med. 2025 Jul 7;14(13):4801. doi: 10.3390/jcm14134801.
7
Health and Economic Impact of Periodic Hepatitis C Virus Testing Among People Who Inject Drugs.注射吸毒者定期丙型肝炎病毒检测的健康与经济影响
JAMA Health Forum. 2025 Jul 3;6(7):e251870. doi: 10.1001/jamahealthforum.2025.1870.
8
Clinical risk factors for hepatocellular carcinoma in Southeast Louisiana: a matched case-control study.路易斯安那州东南部肝细胞癌的临床风险因素：一项配对病例对照研究。
Cancer Causes Control. 2025 Jun 27. doi: 10.1007/s10552-025-02021-3.
9
Simplified and Integrated Hepatitis C Virus Testing and Treatment Algorithm for Unhoused People Who Inject Drugs.针对无家可归的注射吸毒者的简化综合丙型肝炎病毒检测与治疗算法
Open Forum Infect Dis. 2025 May 22;12(6):ofaf302. doi: 10.1093/ofid/ofaf302. eCollection 2025 Jun.
10
Cost-effectiveness analysis of a new paradigm to simplify testing, monitoring and treatment of hepatitis C virus in the United States.美国一种简化丙型肝炎病毒检测、监测和治疗的新范式的成本效益分析。
Cost Eff Resour Alloc. 2025 Jun 4;23(1):25. doi: 10.1186/s12962-025-00622-y.

本文引用的文献

1
A National Hepatitis C Elimination Program in the United States: A Historic Opportunity.美国的全国丙型肝炎消除计划：一个历史性机遇。
JAMA. 2023 Apr 18;329(15):1251-1252. doi: 10.1001/jama.2023.3692.
2
QuickStats: Percentage* of Adults Aged ≥18 Years with Current Hepatitis C Virus Infection, by Health Insurance Coverage - National Health and Nutrition Examination Survey, United States, January 2017-March 2020.快速统计数据：按健康保险覆盖情况划分的≥18岁成年人当前丙型肝炎病毒感染率 - 美国国家健康与营养检查调查，2017年1月至2020年3月
MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1035. doi: 10.15585/mmwr.mm7132a4.
3
Vital Signs: Hepatitis C Treatment Among Insured Adults - United States, 2019-2020.生命体征：2019-2020 年美国参保成年人中的丙型肝炎治疗。
MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1011-1017. doi: 10.15585/mmwr.mm7132e1.
4
National Health and Nutrition Examination Survey, 2017-March 2020 Prepandemic File: Sample Design, Estimation, and Analytic Guidelines.2017 年-2020 年 3 月全国健康与营养调查预流行期文件：抽样设计、估计和分析指南。
Vital Health Stat 1. 2022 May(190):1-36.
5
Characteristics of Persons Treated for Hepatitis C Using National Pharmacy Claims Data, United States, 2014-2020.利用国家药房理赔数据对美国 2014-2020 年丙型肝炎治疗患者特征的研究。
Clin Infect Dis. 2022 Sep 29;75(6):1078-1080. doi: 10.1093/cid/ciac139.
6
Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic.新冠大流行期间丙型肝炎检测和治疗的减少。
Am J Prev Med. 2021 Sep;61(3):369-376. doi: 10.1016/j.amepre.2021.03.011. Epub 2021 May 10.
7
CDC Recommendations for Hepatitis C Screening Among Adults - United States, 2020.美国疾病预防控制中心关于 2020 年成年人丙型肝炎筛查的建议。
MMWR Recomm Rep. 2020 Apr 10;69(2):1-17. doi: 10.15585/mmwr.rr6902a1.
8
Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey.美国慢性病毒性肝炎认知情况：国家健康和营养调查更新。
J Viral Hepat. 2019 May;26(5):596-602. doi: 10.1111/jvh.13060. Epub 2019 Mar 13.
9
Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016.估计 2013-2016 年美国丙型肝炎病毒感染的流行率。
Hepatology. 2019 Mar;69(3):1020-1031. doi: 10.1002/hep.30297. Epub 2018 Nov 6.
10
National Center for Health Statistics Data Presentation Standards for Proportions.国家卫生统计中心比例数据呈现标准
Vital Health Stat 2. 2017 Aug(175):1-22.

美国成年人丙型肝炎病毒感染的估计患病率和知晓率：2017 年 1 月至 2020 年 3 月全国健康和营养调查。

Estimated Prevalence and Awareness of Hepatitis C Virus Infection Among US Adults: National Health and Nutrition Examination Survey, January 2017-March 2020.

机构信息

Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

出版信息

Clin Infect Dis. 2023 Nov 17;77(10):1413-1415. doi: 10.1093/cid/ciad411.

DOI:10.1093/cid/ciad411
PMID:37417196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11000503/
Abstract

During January 2017-March 2020, approximately 2.2 million noninstitutionalized civilian US adults had hepatitis C; one-third were unaware of their infection. Prevalence was substantially higher among persons who were uninsured or experiencing poverty. Unrestricted access to testing and curative treatment is needed to reduce disparities and achieve 2030 elimination goals.

摘要

在 2017 年 1 月至 2020 年 3 月期间，大约有 220 万非机构化的美国成年平民患有丙型肝炎；其中三分之一的人不知道自己被感染。在没有保险或贫困的人群中，患病率要高得多。需要无限制地获得检测和治疗，以减少差距，实现 2030 年消除目标。